Know2eat

Berberine

Berberis vulgaris

Herbs & Botanicals

What berberine may help with

Ranked by how strong the human evidence is — best supported first.

Best supportedBlood glucose responseModerate evidence· 4 sources

Then, in order

About Berberine

An isoquinoline alkaloid extracted from barberry, goldthread, goldenseal and Oregon grape. It is sold as a purified compound rather than a whole-plant extract, which puts it closer to a drug than a herb.

Berberine has a large trial literature in glucose and lipid control, and a large problem with it: the great majority of trials are small, conducted in China, and reviewers repeatedly flag poor methodological quality and probable publication bias. Its oral bioavailability is very low, which sits oddly with the reported effect sizes. It is also a meaningful inhibitor of drug-metabolising enzymes, which makes it a genuine interaction risk rather than a benign botanical.

Sold as
Berberine HCl capsule, Dihydroberberine, Phytosome formulation, Whole-plant extracts
Standardised to
Usually sold as purified berberine hydrochloride at a stated milligram amount — a product without this marker may not resemble what was studied.
Also known as
Berberine HCl, Barberry alkaloid, Huang lian extract

What the research used

The amounts, forms and durations published trials of Berberine actually administered.

These are the amounts published trials administered — not a recommendation, and not a dose to copy. Trial participants were screened, supervised and given a characterised preparation. What is in a retail bottle is frequently not what was studied, and the amount that suits one person is not general advice.

  • Studied for Glycaemic control in type 2 diabetes

    500–1500 mg

    Moderate

    Berberine hydrochloride, divided doses with meals · 8 weeks to 6 months

    Most trials come from Chinese centres and are rated low quality by reviewers, with signs of publication bias. Splitting the dose is universal because a single large dose causes marked digestive upset.

  • Studied for Blood lipids

    500–1500 mg

    Limited

    Berberine hydrochloride, divided doses · 8–24 weeks

    Same literature limitations as the glycaemic trials, with pooled estimates that shift substantially depending on which studies are included.

This is general information about food, not medical advice. It cannot diagnose, treat or replace guidance from a clinician who knows your history.

When it was taken

Each window says whether a trial compared it against an alternative, or whether it is convention and pharmacology. Most timing advice is the second kind.

None of the timings below were directly compared in a trial. They reflect how the research happened to dose, or what the pharmacology implies — which is not the same as a timing being better.

  • Split through the day

    Limited

    Trials universally split the dose across meals, both for tolerability and because the proposed effect is on the post-meal response. The schedule itself has not been compared against alternatives.

    Timing was not directly compared. This reflects convention or how the compound behaves in the body, not a trial showing this window works better.

  • With food

    Not enough

    Taken with meals in nearly every protocol. Absorption differences between fed and fasted states have not been characterised in a way that establishes a best approach.

    Timing was not directly compared. This reflects convention or how the compound behaves in the body, not a trial showing this window works better.

The evidence in depth

Best supported: Moderate

What each association actually rests on, and the papers behind it. A rating describes the state of the research, not how promising the supplement sounds. How we rate evidence.

Blood glucose response

Blood Sugar & Metabolic Health
Moderate evidence

Many randomised trials report reductions in fasting glucose and HbA1c, in some comparisons similar to metformin. Confidence is limited by the trials being small, geographically concentrated, largely low quality and showing signs of publication bias — and this is not a substitute for prescribed diabetes therapy.

What may be going on: Berberine activates AMP-activated protein kinase and alters gut microbial metabolism, both linked to glucose handling in preclinical work.

Moderate evidence. Several human studies point the same way, with real caveats.

View the 4 sources

Deep research mode adds each paper’s own conclusion and stated limitations.

Blood lipid profile

Heart Health
Limited evidence

Pooled trials report reductions in LDL cholesterol and triglycerides. The same quality problems apply, and the effect has not been confirmed in large independent trials outside China.

Limited evidence. Early human work, or mostly lab and animal research.

View the 3 sources

Deep research mode adds each paper’s own conclusion and stated limitations.

Body composition

Weight Management
Not enough evidence

Evidence is limited for berberine and body weight. Reductions reported in trials are small and secondary to metabolic outcomes, and it is marketed far beyond what those results support.

Not enough evidence. Not enough human research to say anything useful yet.

View the 4 sources

Deep research mode adds each paper’s own conclusion and stated limitations.

Things to know

Interactions, contraindications and dose limits, most serious first. Concentrated extracts interact with medication in ways the whole plant does not, so this section carries more weight here than it does on a food page.

  • Interaction

    Hypoglycaemia with diabetes medication

    Interacts withMetformin, insulin, sulfonylureas

    Berberine lowers blood glucose through mechanisms that overlap with metformin and can add to insulin, sulfonylureas or metformin, producing hypoglycaemia. Anyone on those drugs needs prescriber involvement and glucose monitoring rather than a self-directed trial.

  • Interaction

    Broad CYP and transporter inhibition

    Interacts withCiclosporin, statins, CYP3A4 and CYP2D6 substrates, P-glycoprotein substrates

    Berberine inhibits CYP3A4, CYP2D6 and P-glycoprotein, raising blood levels of many medicines including ciclosporin, some statins, calcium channel blockers and certain antidepressants. A human study showed a substantial rise in ciclosporin exposure.

  • Avoid

    Pregnancy, breastfeeding and newborns

    Berberine crosses the placenta and displaces bilirubin from albumin, which is linked to kernicterus in newborns. It is contraindicated in pregnancy, breastfeeding and infancy.

  • Worth knowing

    Digestive upset is very common

    Constipation, diarrhoea, cramping and nausea are frequent, particularly above 500 mg in a single dose, and are the main reason people stop.

  • Worth knowing

    Marketed as a natural alternative to prescribed medicine

    Berberine is widely promoted as a substitute for metformin or for weight-loss drugs. Swapping a monitored prescription for an unregulated supplement with variable content is the practical risk here.

Evidence ratings on this page: 1 moderate evidence, 1 limited evidence, 1 not enough evidence.

Supplements are sold in the US without pre-market review of efficacy or safety. Nothing on this page is a recommendation to take Berberine, or a dose to follow.